Schedule 13G ownership disclosure
ZURA BIO LTD
Security class unavailable · CUSIP: G9TY5A101
Event date: 2023-03-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-041713
- Form type
- SC 13G
- Filer
- Hana Immunotherapeutics LLC
- CIK
- CIK 1972226
- Filed
- Apr 05, 2023
- Reporting period
- Mar 20, 2023
- Description
- Schedule 13G beneficial ownership